IL-2 variant mutant (The Center of Molecular Immunology)
N/A
Report date: 2025/03/20 16:02:45
Base Information
Drug NameIL-2 variant mutant (The Center of Molecular Immunology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCenter Of Molecular Immunology
China Registration ClassN/A
Develop Information
Active CompaniesCenter Of Molecular Immunology
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A